|
My sister was pre-screened for phase II of Lapatinib - clinical trial. I was able to set up a consutation app't for her on June 27th with Dr Harold Burstein at the Dana Farber Cancer institute in Boston.
Does anyone know how it is decided whether or not a patient is eligble for a trial?
|